Interleukin-6 is a potential biomarker for severe pandemic H1N1 influenza A infection.
about
Why does pandemic influenza virus kill?Influenza virus-induced lung inflammation was modulated by cigarette smoke exposure in mice.Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection.Lack of group X secreted phospholipase A₂ increases survival following pandemic H1N1 influenza infection.Viral Etiology of Chronic Obstructive Pulmonary Disease Exacerbations during the A/H1N1pdm09 Pandemic and Postpandemic PeriodAnti-high mobility group box-1 monoclonal antibody treatment provides protection against influenza A virus (H1N1)-induced pneumonia in mice.Differential Immune Profiles in Two Pandemic Influenza A(H1N1)pdm09 Virus Waves at Pandemic Epicenter.Characterization of the Localized Immune Response in the Respiratory Tract of Ferrets following Infection with Influenza A and B VirusesCollectins, H-ficolin and LL-37 reduce influence viral replication in human monocytes and modulate virus-induced cytokine production.Proinflammatory chemokines are major mediators of exuberant immune response associated with Influenza A (H1N1) pdm09 virus infection.Profiles of acute cytokine and antibody responses in patients infected with avian influenza A H7N9Cellular changes in blood indicate severe respiratory disease during influenza infections in miceProduction and differentiation of myeloid cells driven by proinflammatory cytokines in response to acute pneumovirus infection in miceThe association between serum biomarkers and disease outcome in influenza A(H1N1)pdm09 virus infection: results of two international observational cohort studies.Molecular analysis of serum and bronchoalveolar lavage in a mouse model of influenza reveals markers of disease severity that can be clinically useful in humans.Suppressor of cytokine signaling 4 (SOCS4) protects against severe cytokine storm and enhances viral clearance during influenza infection.TGF-β-induced IL-6 prevents development of acute lung injury in influenza A virus-infected F508del CFTR-heterozygous mice.The Interferon-Inducible Mouse Apolipoprotein L9 and Prohibitins Cooperate to Restrict Theiler's Virus ReplicationTranscriptomic and Epigenetic Profiling of the Lung of Influenza-Infected Pigs: A Comparison of Different Birth Weight and Susceptibility Groups.TGF-β Blood Levels Distinguish Between Influenza A (H1N1)pdm09 Virus Sepsis and Sepsis due to Other Forms of Community-Acquired PneumoniaTNF, IL6, and IL1B Polymorphisms Are Associated with Severe Influenza A (H1N1) Virus Infection in the Mexican Population.Inhibition of influenza virus via a sesquiterpene fraction isolated from Laggera pterodonta by targeting the NF-κB and p38 pathways.Saikosaponin A inhibits influenza A virus replication and lung immunopathology.Henipavirus pathogenesis in human respiratory epithelial cellsThe Effect of Oseltamivir on the Disease Progression of Lethal Influenza A Virus Infection: Plasma Cytokine and miRNA Responses in a Mouse ModelAirway CD8(+) T Cells Are Associated with Lung Injury during Infant Viral Respiratory Tract Infection.Type I interferons regulate susceptibility to inflammation-induced preterm birth.Mucosal immune responses predict clinical outcomes during influenza infection independently of age and viral load.Protective effects of phillyrin against influenza A virus in vivo.Efficacy of recombinant measles virus expressing highly pathogenic avian influenza virus (HPAIV) antigen against HPAIV infection in monkeys.Pulmonary transcriptomic responses indicate a dual role of inflammation in pneumonia development and viral clearance during 2009 pandemic influenza infection.Biomarkers for Predicting Illness Severity in Children With Acute Lower Respiratory Tract Infections.Single-walled carbon nanotubes modulate pulmonary immune responses and increase pandemic influenza a virus titers in mice.In vitro anti-influenza virus effect of total flavonoid from Trollius ledebouri Reichb.Molecular modeling and SPRi investigations of interleukin 6 (IL6) protein and DNA aptamers.Entry Inhibition and Modulation of Pro-Inflammatory Immune Response Against Influenza A Virus by a Recombinant Truncated Surfactant Protein DOrally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial VirusesInfluenza Vaccine and Autoimmune Diseases
P2860
Q30352613-80407492-4CAE-4F21-92E3-D9D5E5508CCBQ30358340-2652C086-F192-4F12-8DFE-3E75FD3C8D40Q30360402-6EF86B05-B621-4A89-A6B6-24ADFEAD8F5CQ30361318-32660504-7C44-40DA-8DCC-E45F766F956AQ30375530-77D3E7CA-C365-42D4-828F-FF5C9F8560F4Q30375577-71182C29-1FF9-4BD2-B6FE-B650BEE1B511Q30382796-2CF77714-A1F5-4D25-8C92-6AD83E30B15FQ30383049-C1DF270B-5166-43E5-8A0C-AC7ED63FBED7Q30395313-1476016A-878B-4E94-BCFA-039A879A1084Q30398612-C1742EC7-EA9B-4A99-BB77-7DC051DEE2B8Q33864111-A474E465-35F5-43F8-A92C-205957F5AECCQ33946105-04368A86-0C98-4344-8C9C-4D4209317616Q34289336-8308448C-2CB2-4C0C-BC84-9D42F5D7EA93Q34611788-AAEC05FE-3499-47B0-85E8-7BBDD16D8058Q35088112-C5C72423-2FCA-4975-B9EF-1B09B757587FQ35165316-8E9E7622-143E-4D3E-9C46-DA688925A599Q35672021-B04968B0-7654-44B7-84FF-34D77624D17DQ35702392-2B439A98-97A1-4F0A-80BD-C75BFD1A5707Q35783360-923BF7FB-80CE-4826-AD66-7603C7901F30Q35801633-09746764-0174-4B82-95EB-95EFD90F90EDQ35866610-F616F3ED-FB95-48B6-9879-F8F0D2C8544FQ36243179-CA67EF78-3E52-4CBA-AD64-40444CC5C276Q36618923-E0E8487E-59C8-42E8-B538-7FDAFEE0BB8CQ36667789-60EDC6A1-2CF4-4925-837C-0A1AF2446831Q36775625-8981D93D-809D-47F7-A811-BE6C83C28B1BQ37088332-6B0B11E8-AB32-4E0B-89B4-DB0EC49FCB67Q37677428-C7BB56B0-1DFD-44C4-B774-740FEB6B80E2Q37688511-61A65966-2116-4ADC-A1B5-80A0E2D143E1Q39669619-A654B134-D90B-4669-8462-B8F1002A8092Q41696601-C2ABD254-F5C4-4DDB-B01F-EC586BEB2D13Q42377486-060F76B3-2275-41AA-9F60-4F8F277D7765Q42962568-F3CF6752-86F7-4C97-A83A-E878E048673AQ47132665-505A4804-CE87-4896-B59E-96E0E15494AEQ49996809-6A4C0E4D-8840-41F7-9AB1-1729EC3C1F88Q50954695-368D8588-11F6-4874-BC1B-25D73F6318E5Q57016836-B10B05A7-A60E-4AB5-B1EB-132EF59579D6Q57095720-1BDB2279-990A-41D5-A751-A9D36E160A1CQ58051969-0EF524F8-90D5-48EC-9EEC-76E669014B0B
P2860
Interleukin-6 is a potential biomarker for severe pandemic H1N1 influenza A infection.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Interleukin-6 is a potential biomarker for severe pandemic H1N1 influenza A infection.
@ast
Interleukin-6 is a potential biomarker for severe pandemic H1N1 influenza A infection.
@en
type
label
Interleukin-6 is a potential biomarker for severe pandemic H1N1 influenza A infection.
@ast
Interleukin-6 is a potential biomarker for severe pandemic H1N1 influenza A infection.
@en
prefLabel
Interleukin-6 is a potential biomarker for severe pandemic H1N1 influenza A infection.
@ast
Interleukin-6 is a potential biomarker for severe pandemic H1N1 influenza A infection.
@en
P2093
P2860
P50
P921
P1433
P1476
Interleukin-6 is a potential biomarker for severe pandemic H1N1 influenza A infection
@en
P2093
Alberto J Leόn
Alyson A Kelvin
Barry B Rubin
Bianche Shum
David Andaluz
David Banner
David J Kelvin
Derek C K Ng
P2860
P304
P356
10.1371/JOURNAL.PONE.0038214
P407
P577
2012-06-05T00:00:00Z